Skip to main content

Position Details

Academic Personnel

Acting Instructor, Medical Oncology (Blood Marrow Transplant (BMT) Immunotherapy (IMTX) Program)


Position Overview


School / Campus / College: School of Medicine

Organization: Medicine, Oncology

Title: Acting Instructor, Medical Oncology (Blood Marrow Transplant (BMT) Immunotherapy (IMTX) Program)


Position Details


Position Description

For the Blood and Marrow Transplantation (BMT)/Immunotherapy fellowship, the Fred Hutchinson Cancer Research Center (Fred Hutch) and the University of Washington (UW) Department of Medicine, Division of Medical Oncology are jointly recruiting a full-time faculty member at the Research Associate (Fred Hutch)/Acting Instructor level (UW). This is a full-time, 12-month service period (July 1-June 30), annual appointment. The primary appointment will be in the Clinical Research Division of Fred Hutch.

The Fred Hutch, home of three Nobel laureates, is an independent, nonprofit research institution dedicated to the development and advancement of biomedical research to eliminate cancer and other potentially fatal diseases. Recognized internationally for its pioneering work in BMT and immunotherapy, Fred Hutch and the UW provide a unique environment for conducting translational research and clinical care. The Fred Hutch, in collaboration with its clinical and research partners, UW and Seattle Children’s, is a National Cancer Institute-designated comprehensive cancer center.

This is a year-long fellowship program with the goal of becoming an expert in BMT and immunotherapy. Rotations will include outpatient and inpatient BMT (autologous and allogeneic, long-term follow-up, etc.) and immunotherapy services. The fellow will initially function as a primary provider with direct patient care responsibilities and will have increasing levels of clinical team leadership over the course of the year.  Approximately 8 months will be devoted to clinical activities with the remaining time available for clinically focused research projects.  University of Washington faculty engage in teaching, research, and service.

Anticipated start date: July 1, 2022.

Qualifications

The ideal candidate should have an interest in hematopoietic cell transplantation and/or immunotherapy and should have completed a fellowship in hematology or hematology-oncology (or foreign equivalent). 

Applicants must have a medical doctorate (or foreign equivalent) and be American Board of Internal Medicine (ABIM) eligible or certified in Medical Oncology or Hematology (or foreign equivalent). In order to be eligible for University sponsorship for an H-1B visa, graduates of foreign (non-U.S.) medical schools must show successful completion of all three steps of the U.S. Medical Licensing Exam (USMLE), or equivalent as determined by the Secretary of Health and Human Services.

Instructions

Applicants should submit a C.V.; statement of clinical and research interests; personal statement outlining your interests in the fellowship program; a diversity, inclusion and mentoring statement [describing your past contributions to diversity, equity, and inclusion and your future plans for continuing these efforts (one page or less)]; and contact information for at least three professional references (including your hem/onc fellowship director) to the attention of Andrea Tate.

Equal Employment Opportunity Statement

University of Washington is an affirmative action and equal opportunity employer. All
qualified applicants will receive consideration for employment without regard to race, color, creed,
religion, national origin, sex, sexual orientation, marital status, pregnancy, genetic information,
gender identity or expression, age, disability, or protected veteran status.

Apply now

The University of Washington is using Interfolio's Faculty Search to conduct this search. Applicants to this position receive a free Dossier account and can send all application materials, including confidential letters of recommendation, free of charge.


For help signing up, accessing your account, or submitting your application, please check out Interfolio's help and support section or get in touch via email at help@interfolio.com or phone at (877)997-8807.

Title IX Notice

Title IX, Title VII, VAWA, Washington State law, and University of Washington policy collectively prohibit discrimination based on sex, sexual orientation, gender, gender expression, pregnant or parenting status, and LGBTQ (lesbian, gay, bisexual, transgender, queer) identity.

Anyone may contact the Office of the Title IX Coordinator about sex and gender discrimination, including sexual or gender-based harassment, sexual assault, intimate partner violence, stalking, and other forms of sexual misconduct. Anyone who has experienced these behaviors has the right to make a complaint to the University, report to the police, to both, or not at all.

Please see the Title IX website to learn more about how to report or make a formal complaint of sex discrimination, sexual harassment, or other sexual misconduct. You will also find information about supportive measures and the grievance procedures that are utilized for complaints of sexual harassment and other sexual misconduct. Students and employees have access to support measures and resources, whether or not they choose to make a complaint.

Office of the Title IX Coordinator

Valery Richardson, Title IX Coordinator
Mags Aleks, Deputy Title IX Coordinator
4311 11th Ave NE Seattle, WA 98105
206-221-7932
TitleIX@uw.edu

Commitment to Diversity

The University of Washington is committed to building diversity among its faculty, librarian,
staff, and student communities, and articulates that commitment in the UW Diversity Blueprint
(http://www.washington.edu/diversity/diversity-blueprint/). Additionally, the University’s Faculty Code
recognizes faculty efforts in research, teaching and/or service that address diversity and equal
opportunity as important contributions to a faculty member’s academic profile and
responsibilities (https://www.washington.edu/admin/rules/policies/FCG/FCCH24.html#2432).